BioLife Sciences's net tangible assets is $-110.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (February 2022), BLFE shows a net tangible assets of $-110. That compares with $-710K in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BLFE's net tangible assets is now $-110 (was $-710K) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioLife Sciences is outperforming or lagging.
Tracking BLFE's net tangible assets over time shows whether BioLife Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $-110 That compares with $-710K in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has BioLife Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-110) with ownership activity and broader fundamentals.